Compare BJ & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJ | PEN |
|---|---|---|
| Founded | 1984 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 12.8B |
| IPO Year | 2018 | 2015 |
| Metric | BJ | PEN |
|---|---|---|
| Price | $93.37 | $325.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 16 |
| Target Price | $108.36 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.7M | 476.6K |
| Earning Date | 05-21-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.50 | ★ 1155.56 |
| EPS | 4.38 | ★ 4.52 |
| Revenue | ★ $21,457,274,000.00 | $1,403,665,000.00 |
| Revenue This Year | $8.86 | $14.34 |
| Revenue Next Year | $6.50 | $13.71 |
| P/E Ratio | ★ $21.39 | $72.14 |
| Revenue Growth | 4.66 | ★ 17.50 |
| 52 Week Low | $86.68 | $221.26 |
| 52 Week High | $120.33 | $362.41 |
| Indicator | BJ | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.04 | 38.65 |
| Support Level | $88.16 | $302.19 |
| Resistance Level | $94.88 | $335.61 |
| Average True Range (ATR) | 2.20 | 2.94 |
| MACD | 0.03 | -0.33 |
| Stochastic Oscillator | 43.30 | 15.04 |
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 250 clubs and a growing domestic presence across 21 states. In fiscal 2024, the company generated over $20 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (71% of sales), general merchandise (11%), and gasoline (18%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.